To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

1. house
3. senate
5. president

Introduced January 17, 2023 by Diana Harshbarger · Last progress January 17, 2023